img

Global Autoimmune Monoclonal Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autoimmune Monoclonal Antibodies Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Autoimmune diseases are the condition in which body own immune system mistakenly attack normal body. In autoimmune diseases production of autoantibodies occurs which attack the healthy cell of body. Autoimmune monoclonal antibodies are the agents which acts as immunotherapy agent and protect the body healthy cell from the damage.
Autoimmune Monoclonal Antibodies report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Autoimmune Monoclonal Antibodies market is projected to reach US$ 24710 million in 2029, increasing from US$ 14900 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2029. Demand from Rheumatoid Arthritis and Systemic Lupus Erythematosus are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Autoimmune Monoclonal Antibodies industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Autoimmune Monoclonal Antibodies key manufacturers include F. Hoffmann-La Roche Ltd, Mylan N.V, Sanofi, Pfizer Inc, GSK plc, Novartis AG, Bayer AG, Lilly and Merck & Co., Inc, etc. F. Hoffmann-La Roche Ltd, Mylan N.V, Sanofi are top 3 players and held % sales share in total in 2022.
Autoimmune Monoclonal Antibodies can be divided into TNF Class, Interleukins, Integrins and B-Cell Depletion and Inhibition Targets, etc. TNF Class is the mainstream product in the market, accounting for % sales share globally in 2022.
Autoimmune Monoclonal Antibodies is widely used in various fields, such as Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Organ Transplant Rejection, etc. Rheumatoid Arthritis provides greatest supports to the Autoimmune Monoclonal Antibodies industry development. In 2022, global % sales of Autoimmune Monoclonal Antibodies went into Rheumatoid Arthritis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autoimmune Monoclonal Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


F. Hoffmann-La Roche Ltd
Mylan N.V
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Lupin
Fresenius Kabi AG
Akorn Incorporated
Teva Pharmaceutical Industries Ltd
Segment by Type
TNF Class
Interleukins
Integrins
B-Cell Depletion and Inhibition Targets
T Cell Depletion Targets

Segment by Application


Rheumatoid Arthritis
Systemic Lupus Erythematosus
Multiple Sclerosis
Organ Transplant Rejection
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autoimmune Monoclonal Antibodies market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Autoimmune Monoclonal Antibodies, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Autoimmune Monoclonal Antibodies industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Autoimmune Monoclonal Antibodies in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Autoimmune Monoclonal Antibodies introduction, etc. Autoimmune Monoclonal Antibodies Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Autoimmune Monoclonal Antibodies market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Autoimmune Monoclonal Antibodies Market Overview
1.1 Autoimmune Monoclonal Antibodies Product Overview
1.2 Autoimmune Monoclonal Antibodies Market Segment by Type
1.2.1 TNF Class
1.2.2 Interleukins
1.2.3 Integrins
1.2.4 B-Cell Depletion and Inhibition Targets
1.2.5 T Cell Depletion Targets
1.3 Global Autoimmune Monoclonal Antibodies Market Size by Type
1.3.1 Global Autoimmune Monoclonal Antibodies Market Size Overview by Type (2018-2029)
1.3.2 Global Autoimmune Monoclonal Antibodies Historic Market Size Review by Type (2018-2024)
1.3.3 Global Autoimmune Monoclonal Antibodies Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Autoimmune Monoclonal Antibodies Sales Breakdown by Type (2018-2024)
1.4.2 Europe Autoimmune Monoclonal Antibodies Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Autoimmune Monoclonal Antibodies Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Autoimmune Monoclonal Antibodies Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Autoimmune Monoclonal Antibodies Sales Breakdown by Type (2018-2024)
2 Global Autoimmune Monoclonal Antibodies Market Competition by Company
2.1 Global Top Players by Autoimmune Monoclonal Antibodies Sales (2018-2024)
2.2 Global Top Players by Autoimmune Monoclonal Antibodies Revenue (2018-2024)
2.3 Global Top Players by Autoimmune Monoclonal Antibodies Price (2018-2024)
2.4 Global Top Manufacturers Autoimmune Monoclonal Antibodies Manufacturing Base Distribution, Sales Area, Product Type
2.5 Autoimmune Monoclonal Antibodies Market Competitive Situation and Trends
2.5.1 Autoimmune Monoclonal Antibodies Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Autoimmune Monoclonal Antibodies Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Monoclonal Antibodies as of 2022)
2.7 Date of Key Manufacturers Enter into Autoimmune Monoclonal Antibodies Market
2.8 Key Manufacturers Autoimmune Monoclonal Antibodies Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Autoimmune Monoclonal Antibodies Status and Outlook by Region
3.1 Global Autoimmune Monoclonal Antibodies Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Autoimmune Monoclonal Antibodies Historic Market Size by Region
3.2.1 Global Autoimmune Monoclonal Antibodies Sales in Volume by Region (2018-2024)
3.2.2 Global Autoimmune Monoclonal Antibodies Sales in Value by Region (2018-2024)
3.2.3 Global Autoimmune Monoclonal Antibodies Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Autoimmune Monoclonal Antibodies Forecasted Market Size by Region
3.3.1 Global Autoimmune Monoclonal Antibodies Sales in Volume by Region (2024-2029)
3.3.2 Global Autoimmune Monoclonal Antibodies Sales in Value by Region (2024-2029)
3.3.3 Global Autoimmune Monoclonal Antibodies Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Autoimmune Monoclonal Antibodies by Application
4.1 Autoimmune Monoclonal Antibodies Market Segment by Application
4.1.1 Rheumatoid Arthritis
4.1.2 Systemic Lupus Erythematosus
4.1.3 Multiple Sclerosis
4.1.4 Organ Transplant Rejection
4.1.5 Others
4.2 Global Autoimmune Monoclonal Antibodies Market Size by Application
4.2.1 Global Autoimmune Monoclonal Antibodies Market Size Overview by Application (2018-2029)
4.2.2 Global Autoimmune Monoclonal Antibodies Historic Market Size Review by Application (2018-2024)
4.2.3 Global Autoimmune Monoclonal Antibodies Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Autoimmune Monoclonal Antibodies Sales Breakdown by Application (2018-2024)
4.3.2 Europe Autoimmune Monoclonal Antibodies Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Autoimmune Monoclonal Antibodies Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Autoimmune Monoclonal Antibodies Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Autoimmune Monoclonal Antibodies Sales Breakdown by Application (2018-2024)
5 North America Autoimmune Monoclonal Antibodies by Country
5.1 North America Autoimmune Monoclonal Antibodies Historic Market Size by Country
5.1.1 North America Autoimmune Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Autoimmune Monoclonal Antibodies Sales in Volume by Country (2018-2024)
5.1.3 North America Autoimmune Monoclonal Antibodies Sales in Value by Country (2018-2024)
5.2 North America Autoimmune Monoclonal Antibodies Forecasted Market Size by Country
5.2.1 North America Autoimmune Monoclonal Antibodies Sales in Volume by Country (2024-2029)
5.2.2 North America Autoimmune Monoclonal Antibodies Sales in Value by Country (2024-2029)
6 Europe Autoimmune Monoclonal Antibodies by Country
6.1 Europe Autoimmune Monoclonal Antibodies Historic Market Size by Country
6.1.1 Europe Autoimmune Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Autoimmune Monoclonal Antibodies Sales in Volume by Country (2018-2024)
6.1.3 Europe Autoimmune Monoclonal Antibodies Sales in Value by Country (2018-2024)
6.2 Europe Autoimmune Monoclonal Antibodies Forecasted Market Size by Country
6.2.1 Europe Autoimmune Monoclonal Antibodies Sales in Volume by Country (2024-2029)
6.2.2 Europe Autoimmune Monoclonal Antibodies Sales in Value by Country (2024-2029)
7 Asia-Pacific Autoimmune Monoclonal Antibodies by Region
7.1 Asia-Pacific Autoimmune Monoclonal Antibodies Historic Market Size by Region
7.1.1 Asia-Pacific Autoimmune Monoclonal Antibodies Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Autoimmune Monoclonal Antibodies Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Autoimmune Monoclonal Antibodies Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Autoimmune Monoclonal Antibodies Forecasted Market Size by Region
7.2.1 Asia-Pacific Autoimmune Monoclonal Antibodies Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Autoimmune Monoclonal Antibodies Sales in Value by Region (2024-2029)
8 Latin America Autoimmune Monoclonal Antibodies by Country
8.1 Latin America Autoimmune Monoclonal Antibodies Historic Market Size by Country
8.1.1 Latin America Autoimmune Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Autoimmune Monoclonal Antibodies Sales in Volume by Country (2018-2024)
8.1.3 Latin America Autoimmune Monoclonal Antibodies Sales in Value by Country (2018-2024)
8.2 Latin America Autoimmune Monoclonal Antibodies Forecasted Market Size by Country
8.2.1 Latin America Autoimmune Monoclonal Antibodies Sales in Volume by Country (2024-2029)
8.2.2 Latin America Autoimmune Monoclonal Antibodies Sales in Value by Country (2024-2029)
9 Middle East and Africa Autoimmune Monoclonal Antibodies by Country
9.1 Middle East and Africa Autoimmune Monoclonal Antibodies Historic Market Size by Country
9.1.1 Middle East and Africa Autoimmune Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Autoimmune Monoclonal Antibodies Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Autoimmune Monoclonal Antibodies Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Autoimmune Monoclonal Antibodies Forecasted Market Size by Country
9.2.1 Middle East and Africa Autoimmune Monoclonal Antibodies Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Autoimmune Monoclonal Antibodies Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 F. Hoffmann-La Roche Ltd
10.1.1 F. Hoffmann-La Roche Ltd Company Information
10.1.2 F. Hoffmann-La Roche Ltd Introduction and Business Overview
10.1.3 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.1.4 F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Products Offered
10.1.5 F. Hoffmann-La Roche Ltd Recent Development
10.2 Mylan N.V
10.2.1 Mylan N.V Company Information
10.2.2 Mylan N.V Introduction and Business Overview
10.2.3 Mylan N.V Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Mylan N.V Autoimmune Monoclonal Antibodies Products Offered
10.2.5 Mylan N.V Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi Autoimmune Monoclonal Antibodies Products Offered
10.3.5 Sanofi Recent Development
10.4 Pfizer Inc
10.4.1 Pfizer Inc Company Information
10.4.2 Pfizer Inc Introduction and Business Overview
10.4.3 Pfizer Inc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Inc Autoimmune Monoclonal Antibodies Products Offered
10.4.5 Pfizer Inc Recent Development
10.5 GSK plc
10.5.1 GSK plc Company Information
10.5.2 GSK plc Introduction and Business Overview
10.5.3 GSK plc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.5.4 GSK plc Autoimmune Monoclonal Antibodies Products Offered
10.5.5 GSK plc Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis AG Autoimmune Monoclonal Antibodies Products Offered
10.6.5 Novartis AG Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Company Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Bayer AG Autoimmune Monoclonal Antibodies Products Offered
10.7.5 Bayer AG Recent Development
10.8 Lilly
10.8.1 Lilly Company Information
10.8.2 Lilly Introduction and Business Overview
10.8.3 Lilly Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Lilly Autoimmune Monoclonal Antibodies Products Offered
10.8.5 Lilly Recent Development
10.9 Merck & Co., Inc
10.9.1 Merck & Co., Inc Company Information
10.9.2 Merck & Co., Inc Introduction and Business Overview
10.9.3 Merck & Co., Inc Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Merck & Co., Inc Autoimmune Monoclonal Antibodies Products Offered
10.9.5 Merck & Co., Inc Recent Development
10.10 Sun Pharmaceutical Industries Ltd
10.10.1 Sun Pharmaceutical Industries Ltd Company Information
10.10.2 Sun Pharmaceutical Industries Ltd Introduction and Business Overview
10.10.3 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Products Offered
10.10.5 Sun Pharmaceutical Industries Ltd Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aurobindo Pharma Autoimmune Monoclonal Antibodies Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Lupin
10.12.1 Lupin Company Information
10.12.2 Lupin Introduction and Business Overview
10.12.3 Lupin Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Lupin Autoimmune Monoclonal Antibodies Products Offered
10.12.5 Lupin Recent Development
10.13 Fresenius Kabi AG
10.13.1 Fresenius Kabi AG Company Information
10.13.2 Fresenius Kabi AG Introduction and Business Overview
10.13.3 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Fresenius Kabi AG Autoimmune Monoclonal Antibodies Products Offered
10.13.5 Fresenius Kabi AG Recent Development
10.14 Akorn Incorporated
10.14.1 Akorn Incorporated Company Information
10.14.2 Akorn Incorporated Introduction and Business Overview
10.14.3 Akorn Incorporated Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Akorn Incorporated Autoimmune Monoclonal Antibodies Products Offered
10.14.5 Akorn Incorporated Recent Development
10.15 Teva Pharmaceutical Industries Ltd
10.15.1 Teva Pharmaceutical Industries Ltd Company Information
10.15.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.15.3 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Products Offered
10.15.5 Teva Pharmaceutical Industries Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Autoimmune Monoclonal Antibodies Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Autoimmune Monoclonal Antibodies Industrial Chain Analysis
11.4 Autoimmune Monoclonal Antibodies Market Dynamics
11.4.1 Autoimmune Monoclonal Antibodies Industry Trends
11.4.2 Autoimmune Monoclonal Antibodies Market Drivers
11.4.3 Autoimmune Monoclonal Antibodies Market Challenges
11.4.4 Autoimmune Monoclonal Antibodies Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Autoimmune Monoclonal Antibodies Distributors
12.3 Autoimmune Monoclonal Antibodies Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of TNF Class
Table 2. Major Company of Interleukins
Table 3. Major Company of Integrins
Table 4. Major Company of B-Cell Depletion and Inhibition Targets
Table 5. Major Company of T Cell Depletion Targets
Table 6. Global Autoimmune Monoclonal Antibodies Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (K Units)
Table 8. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US& Million)
Table 10. Global Autoimmune Monoclonal Antibodies Market Share in Value by Type (2018-2024)
Table 11. Global Autoimmune Monoclonal Antibodies Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Autoimmune Monoclonal Antibodies Sales by Type (2024-2029) & (K Units)
Table 13. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Autoimmune Monoclonal Antibodies Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type (2024-2029)
Table 16. Global Autoimmune Monoclonal Antibodies Price by Type (2024-2029) & (US$/Unit)
Table 17. North America Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (K Units)
Table 18. North America Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2018-2024)
Table 20. Europe Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2018-2024)
Table 24. Latin America Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Autoimmune Monoclonal Antibodies Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Autoimmune Monoclonal Antibodies Sales by Company (2018-2024) & (K Units)
Table 28. Global Autoimmune Monoclonal Antibodies Sales Share by Company (2018-2024)
Table 29. Global Autoimmune Monoclonal Antibodies Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Autoimmune Monoclonal Antibodies Revenue Share by Company (2018-2024)
Table 31. Global Market Autoimmune Monoclonal Antibodies Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Autoimmune Monoclonal Antibodies Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Autoimmune Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Monoclonal Antibodies as of 2022)
Table 35. Date of Key Manufacturers Enter into Autoimmune Monoclonal Antibodies Market
Table 36. Key Manufacturers Autoimmune Monoclonal Antibodies Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Autoimmune Monoclonal Antibodies Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (K Units)
Table 40. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Autoimmune Monoclonal Antibodies Sales Market Share in Value by Region (2018-2024)
Table 43. Global Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 45. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Autoimmune Monoclonal Antibodies Sales Market Share in Value by Region (2024-2029)
Table 48. Global Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global Autoimmune Monoclonal Antibodies Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (K Units)
Table 51. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application (2018-2024)
Table 54. Global Autoimmune Monoclonal Antibodies Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Autoimmune Monoclonal Antibodies Sales by Application (2024-2029) & (K Units)
Table 56. Global Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Autoimmune Monoclonal Antibodies Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application (2024-2029)
Table 59. Global Autoimmune Monoclonal Antibodies Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) (K Units)
Table 61. North America Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) (K Units)
Table 63. Europe Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) (K Units)
Table 67. Latin America Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 71. North America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2018-2024)
Table 74. North America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 75. North America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 79. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 83. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Autoimmune Monoclonal Antibodies Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Autoimmune Monoclonal Antibodies Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Value by Country (2024-2029)
Table 110. F. Hoffmann-La Roche Ltd Company Information
Table 111. F. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 112. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. F. Hoffmann-La Roche Ltd Autoimmune Monoclonal Antibodies Product
Table 114. F. Hoffmann-La Roche Ltd Recent Development
Table 115. Mylan N.V Company Information
Table 116. Mylan N.V Introduction and Business Overview
Table 117. Mylan N.V Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Mylan N.V Autoimmune Monoclonal Antibodies Product
Table 119. Mylan N.V Recent Development
Table 120. Sanofi Company Information
Table 121. Sanofi Introduction and Business Overview
Table 122. Sanofi Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sanofi Autoimmune Monoclonal Antibodies Product
Table 124. Sanofi Recent Development
Table 125. Pfizer Inc Company Information
Table 126. Pfizer Inc Introduction and Business Overview
Table 127. Pfizer Inc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Pfizer Inc Autoimmune Monoclonal Antibodies Product
Table 129. Pfizer Inc Recent Development
Table 130. GSK plc Company Information
Table 131. GSK plc Introduction and Business Overview
Table 132. GSK plc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. GSK plc Autoimmune Monoclonal Antibodies Product
Table 134. GSK plc Recent Development
Table 135. Novartis AG Company Information
Table 136. Novartis AG Introduction and Business Overview
Table 137. Novartis AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Novartis AG Autoimmune Monoclonal Antibodies Product
Table 139. Novartis AG Recent Development
Table 140. Bayer AG Company Information
Table 141. Bayer AG Introduction and Business Overview
Table 142. Bayer AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Bayer AG Autoimmune Monoclonal Antibodies Product
Table 144. Bayer AG Recent Development
Table 145. Lilly Company Information
Table 146. Lilly Introduction and Business Overview
Table 147. Lilly Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Lilly Autoimmune Monoclonal Antibodies Product
Table 149. Lilly Recent Development
Table 150. Merck & Co., Inc Company Information
Table 151. Merck & Co., Inc Introduction and Business Overview
Table 152. Merck & Co., Inc Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Merck & Co., Inc Autoimmune Monoclonal Antibodies Product
Table 154. Merck & Co., Inc Recent Development
Table 155. Sun Pharmaceutical Industries Ltd Company Information
Table 156. Sun Pharmaceutical Industries Ltd Introduction and Business Overview
Table 157. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Sun Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product
Table 159. Sun Pharmaceutical Industries Ltd Recent Development
Table 160. Aurobindo Pharma Company Information
Table 161. Aurobindo Pharma Introduction and Business Overview
Table 162. Aurobindo Pharma Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Aurobindo Pharma Autoimmune Monoclonal Antibodies Product
Table 164. Aurobindo Pharma Recent Development
Table 165. Lupin Company Information
Table 166. Lupin Introduction and Business Overview
Table 167. Lupin Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Lupin Autoimmune Monoclonal Antibodies Product
Table 169. Lupin Recent Development
Table 170. Fresenius Kabi AG Company Information
Table 171. Fresenius Kabi AG Introduction and Business Overview
Table 172. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Fresenius Kabi AG Autoimmune Monoclonal Antibodies Product
Table 174. Fresenius Kabi AG Recent Development
Table 175. Akorn Incorporated Company Information
Table 176. Akorn Incorporated Introduction and Business Overview
Table 177. Akorn Incorporated Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Akorn Incorporated Autoimmune Monoclonal Antibodies Product
Table 179. Akorn Incorporated Recent Development
Table 180. Teva Pharmaceutical Industries Ltd Company Information
Table 181. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 182. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Teva Pharmaceutical Industries Ltd Autoimmune Monoclonal Antibodies Product
Table 184. Teva Pharmaceutical Industries Ltd Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Autoimmune Monoclonal Antibodies Market Trends
Table 188. Autoimmune Monoclonal Antibodies Market Drivers
Table 189. Autoimmune Monoclonal Antibodies Market Challenges
Table 190. Autoimmune Monoclonal Antibodies Market Restraints
Table 191. Autoimmune Monoclonal Antibodies Distributors List
Table 192. Autoimmune Monoclonal Antibodies Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Autoimmune Monoclonal Antibodies Product Picture
Figure 2. Global Autoimmune Monoclonal Antibodies Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Autoimmune Monoclonal Antibodies Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Autoimmune Monoclonal Antibodies Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of TNF Class
Figure 6. Global TNF Class Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Interleukins
Figure 8. Global Interleukins Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Integrins
Figure 10. Global Integrins Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of B-Cell Depletion and Inhibition Targets
Figure 12. Global B-Cell Depletion and Inhibition Targets Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of T Cell Depletion Targets
Figure 14. Global T Cell Depletion Targets Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Autoimmune Monoclonal Antibodies Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Autoimmune Monoclonal Antibodies Sales Market Share by Type in 2022 & 2029
Figure 17. North America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 18. North America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 19. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 20. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 23. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Autoimmune Monoclonal Antibodies Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Autoimmune Monoclonal Antibodies Revenue in 2022
Figure 29. Autoimmune Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Rheumatoid Arthritis
Figure 31. Global Rheumatoid Arthritis Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Systemic Lupus Erythematosus
Figure 33. Global Systemic Lupus Erythematosus Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Multiple Sclerosis
Figure 35. Global Multiple Sclerosis Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Product Picture of Organ Transplant Rejection
Figure 37. Global Organ Transplant Rejection Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 40. Global Autoimmune Monoclonal Antibodies Sales by Application (2018-2029) & (US$ Million)
Figure 41. Global Autoimmune Monoclonal Antibodies Sales Market Share by Application in 2022 & 2029
Figure 42. North America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 43. North America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 44. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 45. Europe Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 48. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Autoimmune Monoclonal Antibodies Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Autoimmune Monoclonal Antibodies Manufacturing Cost Structure
Figure 53. Autoimmune Monoclonal Antibodies Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries